Global Tissue Engineering Market, by Material Type (Synthetic, Biological, and Others), by Application (Dermal, Orthopedic, Dental, Neurology, and Others), and by Region Size, Share, Outlook, and Opportunity Analysis, 2023 - 2032
- Published date: Oct 2023
- Report ID: 18193
- Number of Pages: 243
Tissue Engineering Market size is expected to be worth around USD 35.2 Billion by 2032 from USD 12.3 Billion in 2022, growing at a CAGR of 11.4% during the forecast period from 2023 to 2032.
Tissue engineering refers to the creation of functional and three-dimensional tissues using bioactive chemicals, scaffolds, and cells. This includes sciences such as medicine, engineering, cell biology, and molecular biology. It can be used for creating functional structures and can be used in the restoration, preservation, or improvement of damaged tissues or other parts of the body. Tissue engineering involves the fusion of cells with porous scaffold biomaterials in order to aid in the regeneration and repair of damaged tissues. To stimulate tissue growth and serve as templates for tissue regeneration, scaffold biomaterials can be used.
- The Tissue Engineering Market is projected to reach approximately USD 35.2 billion by 2032, with a Compound Annual Growth Rate (CAGR) of 11.4% from 2023 to 2032.
- Synthetic scaffold materials dominate the market, playing a pivotal role in cell proliferation and the restoration of injured organs.
- The orthopedic and musculoskeletal segment is experiencing significant growth, driven by the adoption of tissue-engineered products for bone and cartilage repair.
- The cardiovascular segment is also expected to grow due to an increase in cardiovascular diseases and R&D activities for cardiology-related tissue engineering.
- The growing demand for regenerative medicine, particularly in addressing irreparable tissue damage, and technological advancements in tissue engineering are driving market expansion.
- The orthopedic segment is expected to show the fastest growth due to its relevance in bone tissue engineering, especially for critical skeletal defects.
- Market participants are frequently launching new products and employing various growth strategies in their respective segments to fuel market expansion.
- North America holds the largest share in the tissue engineering market, with significant government and research funding and a high number of clinical trials.
- Europe and the Asia-Pacific region also have substantial market shares, driven by factors like rising chronic diseases, transplant-related issues, and government-funded research initiatives.
Material Type Analysis
Scaffold material accounts for a greater revenue proportion.
On the basis of type, the tissue engineering market is categorized into synthetic scaffold material, biological scaffold material, and others. In 2021, the category for synthetic scaffold materials accounts for a greater revenue proportion. To regulate cell proliferation while creating synthetic tissues, tissue engineering heavily utilizes synthetic scaffolds. The extremely successful synthetic scaffold materials come in two varieties: two-dimensional (2D) and three-dimensional (3D) scaffolds (3D). Synthetic scaffolds with biomimetic components can be assembled to form useful structures that restore, protect, or improve injured organs or organ systems. These elements are causing this segment’s revenue to increase.
In 2021, the market for scaffold materials with biological origins is expected to continue to grow. Biodegradable scaffolds and native extracellular matrices are regarded as permanent templates, whereas biologically generated scaffold material serves as temporary templates and has distinct biological and mechanical comparable properties.
Application Type Analysis
There Is Significant Growth In the Orthopedic And Musculoskeletal Tissue Engineering Market
Based on application type analysis market is divided into dermal, orthopedic, dental, neurology, and others. The adoption of tissue-engineered products for orthopedic and musculoskeletal applications, the commercialization of products for bone and cartilage repair, the availability of a wide range of products, and the rise in musculoskeletal disorders along with increased awareness of these products all point to significant growth for the orthopedic and musculoskeletal tissue engineering market. Due to an increase in cardiovascular disease prevalence and a spike in R&D activities to create tissue-engineered products for cardiology, it is predicted that the cardiovascular segment would have the largest market growth.
Key Market Segments
Based on Type
Based on Application
The Expansion of the Tissue Engineering Market is due to an increase in chronic diseases, trauma injuries, and auto accidents.
Tissue engineering is a market that has seen a rise in chronic diseases, injuries from trauma, and accidents. Due to the severe damage, they do to bones and other organs, traffic accidents are one the leading causes of death. According to the World Health Organization, automobile accidents cause injuries that can be sustained by 20 to 50 million people each year. Tissue engineering is an alternative to surgical reconstruction and mechanical device instruction for the purpose of restoring injured tissues.
Tissue engineering is used in many fields including orthopedics, wound care, burn therapy, and urological products.
The potential for tissue engineering to be extremely helpful in treating pediatric patients is great. There has been an increase in tissue engineering techniques for treating burn wounds. The potential of tissue-engineered skin replacements for wound healing is significant. It is expected that there will be an increase in trauma-related injuries and burns, which will drive the growth of the global tissue engineering market.
Insufficient growth Factor’s Impeding The Market Expansion
Current tissue engineering techniques have many problems, including ineffective cell proliferation, insufficient and unstable growth factor production (which is required to stimulate cell communication and response), and a dearth of biomaterials and techniques that can capture physiological architectures. Biomolecular detection issues and biosensors are two other limitations to tissue engineering. They also make it difficult to manage cell processes and all their properties (biologically, mechanical, and electrochemical). The market is also being held back by the high cost of treatment and slow pace of progress, despite growing interest in tissue engineering research.
Growing Demand for Regenerative Medicine
Market expansion is driven by the promise of tissue engineering treatments that can repair irreparable tissue damage and the growing demand for regenerative medicines. Market growth is due to the increasing demand for regenerative medicine, and the rise in obesity and diabetes. The industry is expected to grow due to other factors such as changing lifestyles, an increase in traumatic injury cases, growing population.
Advancements in Technology In Tissue Engineering
The future growth of the tissue engineering market will be due to technological advances in tissue engineering and in vitro implant design that 3D printers allow. Market growth will be stimulated in part by an increase of reconstructive and replacement operations. Tissue engineering’s immense growth and research are expected to be a major contributor.
Orthopedic Segment is Expected to Show the Fastest Growth During the Forecasting Period
The focus of bone tissue engineering is to implant bone substitutes for critical skeletal defects that cannot heal by themselves. These defects are typical clinical scenarios in orthopedic surgeries for treating bone loss caused by trauma, infection, or tumor resection. Additionally, there are two examples of musculoskeletal conditions for which tissue engineering has emerged as an essential option for orthopedic surgeons, osteochondral defects in the glenohumeral joint and meniscal deficiency in young athletes.
Market participants frequently launch new products and employ a variety of market growth strategies in their respective segments, which is expected to aid in market expansion. For instance, the allograft known as BioEnthesisTM was introduced by Sparta Biopharma Inc., a privately held company. This allograft has layers that are mineralized and demineralized, providing the necessary features for remedial reformation within the rotator cuff. As a result, during the forecasting period, the segment’s growth is anticipated to be significantly fueled by the rising prevalence of orthopedic disorders and the frequent product launches in the respective segment.
North America Holds the Largest Revenue In the Tissue Engineering Market
In 2022, the tissue engineering market’s largest revenue share was held by North America. The American Cancer Society estimates that chronic lymphocytic leukemia (CLL) will account for 4,410 deaths in the previous year, driving market revenue growth in the United States. Tissue engineering research and development enjoys significant government and research institute funding, making the United States a leading market.
The Endocrine Society of the United States claims that the National Institutes of Health (NIH) spends more than USD 40 billion annually on national medical research. Additionally, the United States Food and Drug Administration’s (FDA) increasing number of clinical trials of tissue engineering products and engagement of leading medical research institutes are significant contributors to market expansion.
In 2022 Europe held a steady revenue share of the tissue engineering market. Market revenue is growing in the region due to the rising incidence of chronic diseases like cancer and transplant-related deaths. Around 420 people died while waiting for a transplant, according to NHS Blood and Transplant, and 7,000 people in the UK are on the transplant waiting list. Over the forecast period, these things are expected to get worse, which will drive up market revenue in Europe.
In addition, functionalized scaffolds, 3D in vitro cell culture models, regenerative medicine, and therapeutic treatments are being commercialized by a number of prominent medical research institutes, including the Institute for Technology-Inspired Regenerative Medicine (MERLN) in the Netherlands and Maastricht University. Europe’s market revenue growth is significantly being driven by these developments.
In 2022, the tissue engineering market had a moderate revenue share dominated by the Asia-Pacific region. This region’s market revenue growth is being driven by a large patient population, new treatments for periodontal disorders, and government-funded R&D initiatives. Tissue engineering is increasingly being used to treat patients at a number of leading medical institutions. The growth of this region is significantly fueled by these factors.
- North America
- The US
- Western Europe
- The UK
- Rest of Western Europe
- Eastern Europe
- The Czech Republic
- Rest of Eastern Europe
- South Korea
- Australia & New Zealand
- Rest of APAC
- Latin America
- Costa Rica
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- United Arab Emirates
- Rest of MEA
Key Players Analysis
It has been determined that the key factors for chronic diseases, trauma injuries, and road accidents on the road are all contributing factors to the expansion of tissue engineering solutions. Due to the rising prevalence of chronic diseases, traumatic injuries, and longer lifespans, an increasing number of people are in need of bone implants. The World Health Organization (WHO) Report says that 20-50 million people get non-fatal injuries every year, and many of them end up with disabilities as a result.
People from lower socioeconomic backgrounds are more likely to be in car accidents on the road, even in wealthy nations. As a result, the expected market share can increase in road accidents that result in injuries. Despite the fact that the procedures look very promising for treating a variety of conditions involving tissue damage; One of the main factors that prevents patients from undergoing these procedures is the high cost.
Below are the top Tissue Engineering Market Industry Major players.
Market Key Players
Major players are entering into agreements and collaborations to gain a competitive edge over their competitors. For instance, in March 2019, MyungMoon and ACell and Bio Co. Ltd., signed an exclusive distribution agreement for the distribution of ACell’s Cytal Wound Matrix and MicroMatrix wound management solutions in South Korea. MyungMoon is a reputed distributor and manufacturer of drugs and medical devices in South Korea.
- Baxter International
- Organovo Holdings Inc
- Integra LifeSciences
- DePuy Synthes
- Cook Medical
- Other Key Players
- 3D Systems, the industry leader in 3D printers, announced that it had purchased Additive Works GmbH, a German software company, in May 2021 to improve its simulation capabilities and speed up its processes for large-scale 3D printing.
- The 2022 Symposium on Advanced Wound Care Spring Conference (SAWC) will present the latest Organogenesis wound care research. It will take place in Phoenix Arizona between April 6-10, 2022.
- MyungMoon Bio Co. Ltd. and ACell signed a distribution agreement to sell wound treatment products MicroMatrix in South Korea in March 2019. MyungMoon is a well-known distributor and manufacturer of medical supplies in South Korea.
Report Features Description Market Value (2022) US$ 12.3 Bn Forecast Revenue (2032) US$ 35.2 Bn CAGR (2023-2032) 11.45% Base Year for Estimation 2022 Historic Period 2016-2022 Forecast Period 2023-2032 Report Coverage Revenue Forecast, Market Dynamics, COVID-19 Impact, Competitive Landscape, Recent Developments Segments Covered Based By Material Type-Synthetic, Biological and others; Based by Application- Dermal, Orthopedic, Dental, Neurology, and Others Regional Analysis North America – The US, Canada, & Mexico; Western Europe – Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, & Rest of Western Europe; Eastern Europe – Russia, Poland, The Czech Republic, Greece, & Rest of Eastern Europe; APAC – China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, & Rest of APAC; Latin America – Brazil, Colombia, Chile, Argentina, Costa Rica, & Rest of Latin America; the Middle East & Africa – Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, & Rest of MEA Competitive Landscape Stryker, Allergan, Medtronic, Baxter International, Organovo Holdings Inc, Zimmer, Integra LifeSciences, DePuy Synthes, Cook Medical, Acelity and Other Key Players Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements. Purchase Options We have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF)
Frequently Asked Questions (FAQ)How much is the Global Tissue Engineering Market worth?
Global Tissue Engineering Market market size is Expected to Reach USD 35 Bn by 2032.What was the Market Segmentation of the Tissue Engineering Market?
Based By Material Type-Synthetic, Biological and others; Based by Application- Dermal, Orthopedic, Dental, Neurology, and OthersWho are the major players operating in the Tissue Engineering Market?
Stryker, Allergan, Medtronic, Baxter International, Organovo Holdings Inc, Zimmer, Integra LifeSciences, DePuy Synthes, Cook Medical, Acelity and Other Key PlayersWhich region will lead the Global Tissue Engineering Market?
North America is estimated to be the fastest-growing region during the forthcoming years.
| Single User
USD / per unit
| Multi User
USD / per unit
| Corporate User
USD / per unit
|Report Library Access
|Data Set (Excel)
|Company Profile Library Access
|up to 10 hrs work
|up to 30 hrs work
|up to 20 hrs
|up to 40 hrs
|up to 50 hrs
|Up to 20% off on next purchase
|Up to 25% off on next purchase
|Up to 30% off on next purchase
|Buy Now ($ 3,499)
|Buy Now ($ 4,299)
|Buy Now ($ 4,999)